Fact Table | |
---|---|
Formula | C17H16ClNO |
License | EU EMA, US DailyMed, US FDA |
Bioavailability | 35% |
Legal status | Rx-Only |
Chemical Name | Asenapine |
Elimination half-life | 24 hours |
Dosage (Strength) | 5mg Sublingual, 10mg Sublingual, 10mg (Tablets) |
Pregnancy | Consult Doctor |
Brands | Saphris |
Protein binding | 95% |
PubChem CID | 163091 |
MedlinePlus | a610015 |
ChEBI | 71253 |
ATC code | N05AH05 |
DrugBank | DB06216 |
KEGG | D11769 |
Routes of administration | Sublingual, by mouth |
This medicine an antipsychotic used to treat schizophrenia. It is also used to treat acute manic or mixed episodes associated with bipolar disorder (manic-depression).
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (e.g., different shape or color), as trademark laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.